Evaluation of a Lifestyle Medicine Practice
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The main objective of the study is to evaluate the effectiveness of the PI's lifestyle medicine practice over time.
Sub-objectives are:
- Understand variables that affect success in application of lifestyle medicine to lead to improved patient outcomes.
- Develop a model for practice evaluation that can be utilized for board certification of providers and practices that utilize lifestyle medicine.
- Evaluate the reimbursement success of lifestyle medicine services as a factor of billing codes and insurance providers.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Athens, Ohio, United States, 45701
- Ohio University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients who are seen by the PI in his lifestyle medicine practice at Muntean Health Care.
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Lifestyle Medicine
Patients presenting for lifestyle medicine treatment to prevent, arrest or reverse chronic lifestyle related diseases.
|
Treatment modalities consist of encouraging a plant based, whole food diet, physical activity, stress management, healthy sleep, control of unhealthy habits.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diastolic Blood Pressure
Time Frame: 1 year
|
change in diastolic blood pressure
|
1 year
|
|
Weight
Time Frame: 1 year
|
change in weight
|
1 year
|
|
Systolic Blood Pressure
Time Frame: 1 year
|
change in systolic blood pressure
|
1 year
|
|
Glycosylated hemoglobin
Time Frame: 1 year
|
change in glycosylated hemoglobin
|
1 year
|
|
Total cholesterol
Time Frame: 1 year
|
change in total cholesterol
|
1 year
|
|
low density lipoprotein cholesterol
Time Frame: 1 year
|
change in low density lipoprotein cholesterol
|
1 year
|
|
triglycerides
Time Frame: 1 year
|
change in triglycerides
|
1 year
|
|
high density lipoprotein cholesterol
Time Frame: 1 year
|
change in high density lipoprotein cholesterol
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
steps
Time Frame: 1 year
|
average number of steps per day
|
1 year
|
|
exercise
Time Frame: 1 year
|
average minutes of exercise per day
|
1 year
|
|
fiber
Time Frame: 1 year
|
average grams of fiber consumed on a daily basis
|
1 year
|
|
legumes
Time Frame: 1 year
|
average quantity of legumes consumed on a daily basis
|
1 year
|
|
full plate
Time Frame: 1 year
|
average percent of plate filled with foods high in fiber and water
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 18-X-220
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.